Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kun-Yuan Lin
Delivery of a Survivin Promoter-Driven Antisense Survivin-Expressing Plasmid DNA as a Cancer Therapeutic: A Proof-Of-Concept Study
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Survivin Is a Therapeutic Target in Merkel Cell Carcinoma
Science Translational Medicine
Medicine
Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer
Asian Pacific Journal of Cancer Prevention
XIAP and Survivin as Therapeutic Targets for Radiation Sensitization in Preclinical Models of Lung Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
HLA-A24 and Survivin: Possibilities in Therapeutic Vaccination Against Cancer
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Survivin as a Novel Target Protein for Reducing the Proliferation of Cancer Cells (Review)
Biomedical Reports
Genetics
Pharmacology
Molecular Biology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Application of Quantum Dots as Vectors in Targeted Survivin Gene siRNA Delivery
OncoTargets and Therapy
Oncology
Pharmacology
High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes
Frontiers in Oncology
Cancer Research
Oncology
ZIC1 Acts a Tumor Suppressor in Breast Cancer by Targeting Survivin
International Journal of Oncology
Cancer Research
Oncology
Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy
Drug Discovery Today: Therapeutic Strategies